A retrospective study of magnetic resonance-guided focused ultrasound ablation for uterine myoma in Taiwan
| Autor: | Chi-Ming Lee, Sheng-Ling Tung, Ting-Ywan Chou, Hung-Shi Tseng |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
Ablation Techniques
Adult medicine.medical_specialty Uterine fibroids medicine.medical_treatment Taiwan Symptom Severity Score (SSS) lcsh:Gynecology and obstetrics Focused ultrasound 030218 nuclear medicine & medical imaging 03 medical and health sciences 0302 clinical medicine Quality of life Ultrasonic Surgical Procedures Obstetrics and Gynaecology medicine Humans Uterine myoma magnetic resonance-guided focused ultrasound surgery (MRFUS) uterine fibroids lcsh:RG1-991 Retrospective Studies 030219 obstetrics & reproductive medicine medicine.diagnostic_test business.industry quality of life score (QOLS) Obstetrics and Gynecology Magnetic resonance imaging Retrospective cohort study Middle Aged medicine.disease Ablation Magnetic Resonance Imaging Myoma female genital diseases and pregnancy complications SSS Treatment Outcome Surgery Computer-Assisted Uterine Neoplasms Quality of Life Female Radiology business Follow-Up Studies |
| Zdroj: | Taiwanese Journal of Obstetrics & Gynecology, Vol 55, Iss 5, Pp 646-649 (2016) |
| ISSN: | 1028-4559 |
| Popis: | Objective To report our experiences with 40 patients who were treated with magnetic resonance-guided focused ultrasound surgery (MRgFUS) for uterine fibroids and their 6-month follow-up status. Materials and Methods A total of 40 patients with uterine fibroids underwent MRgFUS from January 2009 to November 2011. The Uterine Fibroid Symptoms and Quality of Life Questionnaire was used to determine the patients' Symptom Severity Scores (SSS) prior to and 6 months after treatment. The nonperfused volume (NPV) values and NPV ratio were obtained immediately at the end of the treatment and at 6 months follow-up. Results No procedure-related complications were noted throughout the 6-month follow-up period among the 40 patients who underwent MRgFUS for uterine fibroids. The mean reduction in SSS in our patients after 6 months was 43.7%, and the mean reduction of fibroid volume was 31.7%. In addition, the mean reduction of NPV and mean NPV ratio was 52.7% and 33.3%, respectively. Conclusion The results obtained from this study demonstrated that MRgFUS can be safely and effectively used to ablate uterine fibroids to produce a significant decrease in mean fibroid volume and improve SSS for up to 6 months after treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|